Prabhakar Reddy

479 total citations · 1 hit paper
10 papers, 318 citations indexed

About

Prabhakar Reddy is a scholar working on Molecular Biology, Organic Chemistry and Molecular Medicine. According to data from OpenAlex, Prabhakar Reddy has authored 10 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Molecular Medicine. Recurrent topics in Prabhakar Reddy's work include Retinoids in leukemia and cellular processes (2 papers), Curcumin's Biomedical Applications (2 papers) and Vanadium and Halogenation Chemistry (1 paper). Prabhakar Reddy is often cited by papers focused on Retinoids in leukemia and cellular processes (2 papers), Curcumin's Biomedical Applications (2 papers) and Vanadium and Halogenation Chemistry (1 paper). Prabhakar Reddy collaborates with scholars based in United States, Poland and India. Prabhakar Reddy's co-authors include Alexander A. Kolykhalov, Negar Makhsous, Jeong-Joong Yoon, M. N. Hart, Ryan C. Shean, Gregory R. Bluemling, Richard K. Plemper, Robert M. Cox, Märt Toots and Roland Plesker and has published in prestigious journals such as Applied Catalysis B: Environmental, Journal of Hepatology and Science Translational Medicine.

In The Last Decade

Prabhakar Reddy

8 papers receiving 311 citations

Hit Papers

Characterization of orally efficacious influenza drug wit... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prabhakar Reddy United States 5 183 97 83 41 33 10 318
Béatrice Silvia Orena Italy 10 93 0.5× 156 1.6× 49 0.6× 17 0.4× 92 2.8× 18 304
Zheng Yao Low Malaysia 8 159 0.9× 80 0.8× 32 0.4× 7 0.2× 16 0.5× 12 289
Nathalie Lecat‐Guillet France 10 106 0.6× 172 1.8× 44 0.5× 16 0.4× 47 1.4× 11 304
Yingna Cai United States 7 50 0.3× 162 1.7× 34 0.4× 70 1.7× 62 1.9× 9 359
P Beena India 5 116 0.6× 48 0.5× 180 2.2× 10 0.2× 21 0.6× 23 387
Qingjie Xiao China 12 80 0.4× 199 2.1× 22 0.3× 20 0.5× 22 0.7× 27 354
Mutaib M. Mashraqi Saudi Arabia 12 67 0.4× 184 1.9× 31 0.4× 13 0.3× 80 2.4× 36 364
Maren Bormann Germany 9 79 0.4× 72 0.7× 15 0.2× 27 0.7× 7 0.2× 12 338
Ana Ribeiro Italy 11 253 1.4× 241 2.5× 152 1.8× 66 1.6× 88 2.7× 15 458

Countries citing papers authored by Prabhakar Reddy

Since Specialization
Citations

This map shows the geographic impact of Prabhakar Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabhakar Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabhakar Reddy more than expected).

Fields of papers citing papers by Prabhakar Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prabhakar Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabhakar Reddy. The network helps show where Prabhakar Reddy may publish in the future.

Co-authorship network of co-authors of Prabhakar Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Prabhakar Reddy. A scholar is included among the top collaborators of Prabhakar Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prabhakar Reddy. Prabhakar Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
3.
Kalmode, Hanuman P., et al.. (2022). Small-Molecule Inhibitors of the MLL1 CXXC Domain, an Epigenetic Reader of DNA Methylation. ACS Medicinal Chemistry Letters. 13(8). 1363–1369. 3 indexed citations
4.
Toots, Märt, Jeong-Joong Yoon, Robert M. Cox, et al.. (2019). Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Science Translational Medicine. 11(515). 233 indexed citations breakdown →
5.
Zhu, Shijun, Terry W. Moore, Randy B. Howard, et al.. (2014). Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts. Current Cancer Drug Targets. 14(4). 380–393. 13 indexed citations
6.
Zhu, Shijun, Terry W. Moore, Xiaoqian Lin, et al.. (2012). Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts. Integrative Biology. 4(6). 633–640. 37 indexed citations
8.
Reddy, Prabhakar, Zelda R. Wasserman, Karl D. Hardman, et al.. (1998). Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases. Bioorganic & Medicinal Chemistry Letters. 8(7). 837–842. 23 indexed citations
9.
Reddy, Prabhakar, et al.. (1988). Ru(III) Catalysed Oxidation of Aminoacids by N-Bromosuccinimide in Aqueous Acetic Acid: A Kinetic Study. Zeitschrift für Physikalische Chemie. 269O(1). 1253–1259. 1 indexed citations
10.
Reddy, Prabhakar, et al.. (1976). NEW 5-SUBSTITUTED-2-FURALDEHYDES. Organic Preparations and Procedures International. 8(6). 302–305. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026